Beyond the Text: GLP-1 Drugs and Insurance Risk - A New Frontier for Health and Life Insurers
 |
 |
Beyond the Text: GLP-1 Drugs and Insurance Risk - A New Frontier for Health and Life Insurers
GLP-1 drugs are changing more than healthcare—they are creating new considerations for insurers across underwriting, claims, and long-term risk assessment.
In this episode of Beyond the Text, Alyssa Gittleman speaks with Mary Pat Campbell about how GLP-1 therapies are influencing both health and life insurers. The discussion explores the complexities of coverage and access, the importance of patient adherence, and the challenges insurers face when balancing short-term costs with long-term outcomes.
The conversation also examines how life insurers are adapting underwriting practices as GLP-1 use becomes more widespread, and why these therapies are highlighting broader differences between how health and life insurers evaluate risk. As adoption continues to grow and new applications emerge, GLP-1 drugs remain an important trend for insurers to monitor.
In this episode of Beyond the Text, Alyssa Gittleman speaks with Mary Pat Campbell about how GLP-1 therapies are influencing both health and life insurers. The discussion explores the complexities of coverage and access, the importance of patient adherence, and the challenges insurers face when balancing short-term costs with long-term outcomes.
The conversation also examines how life insurers are adapting underwriting practices as GLP-1 use becomes more widespread, and why these therapies are highlighting broader differences between how health and life insurers evaluate risk. As adoption continues to grow and new applications emerge, GLP-1 drugs remain an important trend for insurers to monitor.
Also Available On:
Episode Archive
2024: Growth in the Annuity Reinsurance Market
 |
 |
 |
|
2024: Small Commercial Insurance Market: Opportunities to Compete
|
 |
 |
2024: Conning's Program Market Insights
 |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
 |
All investment performance information included in this podcast is historical. Past performance is not a guarantee of future results. Any tax-related information contained in this podcast is for informational purposes only and should not be considered tax advice. You should consult a tax professional with any questions.
For complete details regarding Conning and its services in the U.S., you should refer to our Form ADV Part 2, which may be obtained by calling us.
Legal Disclaimer ©2024 Conning, Inc. This podcast and the software described within are copyrighted with all rights reserved. No part of this podcast may be distributed, reproduced, transcribed, transmitted, stored in an electronic retrieval system, or translated into any language in any form by any means without the prior written permission of Conning. Conning does not make any warranties, express or implied, in this podcast. In no event shall Conning be liable for damages of any kind arising out of the use of this podcast or the information contained within it. This podcast is not intended to be complete, and we do not guarantee its accuracy. Any opinion expressed in this podcast is subject to change at any time without notice.
This podcast contains information that is confidential or proprietary to Conning (or their direct or indirect subsidiaries). By accepting this podcast you agree that: (1) if there is any pre-existing contract containing disclosure and use restrictions between your company and Conning, you and your company will use the information in this podcast in reliance on and subject to the terms of any such pre-existing contract; or (2) if there is no contractual relationship between you and your company and Conning, you and your company agree to protect the information in this podcast and not to reproduce, disclose or use the information in any way, except as may be required by law.
ADVISE®, FIRM®, GEMS® , CONNING CLIMATE RISK ANALYZER ® and CONNING ALLOCATION OPTIMIZER ® are registered trademarks of Conning, Inc. in the U.S. Copyright 1990-2024 Conning, Inc. All rights reserved. ADVISE®, FIRM®, GEMS®, CONNING CLIMATE RISK ANALYZER ® and CONNING ALLOCATION OPTIMIZER ® are proprietary software published and owned by Conning, Inc.
This podcast is for informational purposes only and should not be interpreted as an offer to sell, or a solicitation or recommendation of an offer to buy any security, product or service, or retain Conning for investment advisory services. This discussion may include predictions, estimates, or other information that might be considered forward-looking. While this content represents our current judgment on what the future may hold, it is not a guarantee and the investment market is subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on the content of this podcast, which reflects our opinions only as of the date of this presentation. Nothing contained herein is meant to be investment advice.
For complete details regarding Conning and its services in the U.S., you should refer to our Form ADV Part 2, which may be obtained by calling us.
Legal Disclaimer ©2024 Conning, Inc. This podcast and the software described within are copyrighted with all rights reserved. No part of this podcast may be distributed, reproduced, transcribed, transmitted, stored in an electronic retrieval system, or translated into any language in any form by any means without the prior written permission of Conning. Conning does not make any warranties, express or implied, in this podcast. In no event shall Conning be liable for damages of any kind arising out of the use of this podcast or the information contained within it. This podcast is not intended to be complete, and we do not guarantee its accuracy. Any opinion expressed in this podcast is subject to change at any time without notice.
This podcast contains information that is confidential or proprietary to Conning (or their direct or indirect subsidiaries). By accepting this podcast you agree that: (1) if there is any pre-existing contract containing disclosure and use restrictions between your company and Conning, you and your company will use the information in this podcast in reliance on and subject to the terms of any such pre-existing contract; or (2) if there is no contractual relationship between you and your company and Conning, you and your company agree to protect the information in this podcast and not to reproduce, disclose or use the information in any way, except as may be required by law.
ADVISE®, FIRM®, GEMS® , CONNING CLIMATE RISK ANALYZER ® and CONNING ALLOCATION OPTIMIZER ® are registered trademarks of Conning, Inc. in the U.S. Copyright 1990-2024 Conning, Inc. All rights reserved. ADVISE®, FIRM®, GEMS®, CONNING CLIMATE RISK ANALYZER ® and CONNING ALLOCATION OPTIMIZER ® are proprietary software published and owned by Conning, Inc.
This podcast is for informational purposes only and should not be interpreted as an offer to sell, or a solicitation or recommendation of an offer to buy any security, product or service, or retain Conning for investment advisory services. This discussion may include predictions, estimates, or other information that might be considered forward-looking. While this content represents our current judgment on what the future may hold, it is not a guarantee and the investment market is subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on the content of this podcast, which reflects our opinions only as of the date of this presentation. Nothing contained herein is meant to be investment advice.
Also Available On:
Thank you for subscribing!
© Conning Holdings Limited 2026. All Rights Reserved.Securities are offered through Conning Investment Products, Inc., One Financial Plaza, Hartford, CT 06103 an affiliated broker-dealer. Member of FINRA / SIPC.
